Evidence map›Paper›PMID 42791857›Full record

ArticleBioengineering (Basel, Switzerland)2026

AI-Driven Three-Dimensional Reconstruction of Fetal Cardiovascular Pathways from Ultrasound Sweep Videos for Congenital Heart Disease Screening.

Naoaki Harada, Masaaki Komatsu, Naoki Teraya, Shohei Wakisaka, Katsuji Takeda, Takashi Natsume, Tomonori Taniguchi, Nobuji Kouno, Satoshi Takahashi, Ken Asada and 7 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Naoaki HaradaDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Masaaki KomatsuDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-0421-8085
Naoki TerayaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0009-0005-1296-8152
Shohei WakisakaDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Katsuji TakedaDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.ORCID 0009-0006-8053-8098
Takashi NatsumeDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0002-8240-0264
Tomonori TaniguchiDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0009-0007-4428-0779
Nobuji KounoDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Satoshi TakahashiDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Ken AsadaDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-0548-4449
Syuzo KanekoDivision of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-4558-9800
Mayumi KanekoDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0002-0613-446X
Reina KomatsuDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0009-0008-7681-9051
Kazuki IwamotoDigital Health Platform Development Office, Healthcare Business Unit, Fujitsu Japan Ltd., 1-5 Omiya-cho, Saiwai-ku, Kawasaki 212-0014, Japan.
Ryu MatsuokaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0003-0354-4145
Akihiko SekizawaDepartment of Obstetrics and Gynecology, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.ORCID 0000-0003-2249-1333
Ryuji HamamotoDepartment of NCC Cancer Science, Biomedical Science and Engineering Track, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.ORCID 0000-0002-2632-1334

Funding

Cabinet Office BRIDGEJapan Society for the Promotion of Science JP21K09456Japan Society for the Promotion of Science JP24K12634Japan Society for the Promotion of Science JP25K15973
6 · The paper itself

Abstract

Fetal cardiac ultrasound screening is vital for the prenatal diagnosis of congenital heart disease (CHD). However, understanding complex cardiovascular structures and continuity from two-dimensional (2D) ultrasound images remains challenging. Therefore, this study developed and evaluated an artificial intelligence (AI)-based three-dimensional (3D) visualization approach that reconstructs fetal cardiovascular structures from 2D ultrasound sweep video. To this end, information from the adjacent frames was used. Instead of interpreting each ultrasound frame independently, this method incorporates neighboring frames, enabling the continuous visualization of the right- and left-sided functional circulatory pathways. Our method achieved a mean Dice coefficient of 0.785 on an independent test dataset, demonstrating that the adjacent frame information can provide stable 3D segmentation. Diffusion-based anatomical plausibility analysis trained exclusively on normal anatomies showed exploratory discrimination between normal fetuses and fetuses with CHD (AUC, 0.861; 95% CI, 0.695-0.980). In a clinical comparison study involving 12 obstetricians, the introduction of this AI-driven 3D cardiovascular visualization slightly improved the screening accuracy from 0.779 to 0.808 and significantly improved the confidence-weighted accuracy score (

Indexed as

artificial intelligencecardiovascular structurescontinuityfetal cardiac ultrasound screeningthree-dimensional visualization

Identifiers

PMID42791857
PMCPMC13603691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.